未登录

N

Nicole DellaGioia

yale

H指数:19

被引数:2,919

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Medication status is associated with metabotropic glutamate receptor 5 availability in bipolar disorder and with measures of attention, anhedonia, and cognition

用药状态与双相障碍中代谢型谷氨酸受体5的可用性相关，并与注意力、快感缺乏和认知的测量指标相关

Journal of Affective Disorders

IF4.9

2026-04-270

OAAI

In vivo evidence for metabotropic glutamate receptor 5 dysregulation in chronic pain

在慢性疼痛中存在代谢性谷氨酸受体5失调的体内证据

Neuropsychopharmacology

IF7.1

2025-12-190

PRE

Neural Signatures of Bipolar Disorder and Psychotropic Medication Effects: A Multimodal PET–MRI Study

双相障碍与精神药物效应的神经特征：一项多模态PET-MRI研究

Biological Psychiatry

IF9

2025-11-290

PRE

Nicotine Use and Metabotropic Glutamate Receptor 5 (mGluR5) in Individuals With Major Depressive and Post Traumatic Stress Disorders

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2024-07-010

PRE

Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder

BIOLOGICAL PSYCHIATRY

IF9

2023-06-0110

OAAI

Imaging the effect of ketamine on synaptic density (SV2A) in the living brain

MOLECULAR PSYCHIATRY

IF10.1

2022-02-1537

OAAI

Measuring the effects of ketamine on mGluR5 using [18F]FPEB and PET

使用 [18F]FPEB和PET测量氯胺酮对mGluR5的影响

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

IF4.5

2019-11-1916

OAAI

In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation

mGluR5失调作为自杀意念生物标志物的体内证据

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2019-05-1332

OAAI

Synaptic Density Alterations are Associated With Depression Severity and Network Alterations

突触密度改变与抑郁严重程度和网络改变有关

BIOLOGICAL PSYCHIATRY

IF9

2019-05-010

PREAI

Differential Effects of Ketamine on Mood Symptoms and Cognitive Function in MDD and PTSD

BIOLOGICAL PSYCHIATRY

IF9

2019-05-010

PREAI

Lower synaptic density is associated with depression severity and network alterations

较低的突触密度与抑郁严重程度和网络改变有关

NATURE COMMUNICATIONS

IF15.7

2019-04-04308

OAAI

Preliminary Evidence for Altered Synaptic Density and a Possible Role for Accelerated Ageing in Individuals With MDD as Measured With [11C]UCB-J PET

BIOLOGICAL PSYCHIATRY

IF9

2018-05-014

PREAI

Preliminary Evidence for mGluR5 Dysregulation in Borderline Personality Disorder and Relationship to Suicidal Behavior

BIOLOGICAL PSYCHIATRY

IF9

2018-05-012

PREAI

Multimodal Investigation of Network Level Effects Using Intrinsic Functional Connectivity, Anatomical Covariance, and Structure-to-Function Correlations in Unmedicated Major Depressive Disorder

NEUROPSYCHOPHARMACOLOGY

IF7.1

2017-09-2557

OAAI

Preliminary evidence concerning the pattern and magnitude of cognitive dysfunction in major depressive disorder using cogstate measures

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2017-08-0123

OAAI

Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2017-07-17106

OAAI

Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study

BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING

IF4.8

2017-07-0159

OAAI

In Vivo Quantification of mGluR5 Availability in Posttraumatic Stress Disorder

BIOLOGICAL PSYCHIATRY

IF9

2017-05-011

PREAI

In Vivo Evidence of Lower Synaptic Density in Depression and Associated Mood and Cognitive Deficits: A [11C]UCB-J PET Imaging Study

BIOLOGICAL PSYCHIATRY

IF9

2017-05-013

PREAI

Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [11C]ABP688 and PET imaging study in depression

MOLECULAR PSYCHIATRY

IF10.1

2017-04-11108

OAAI